Bel Fuse Inc Cl B (BELFB) 22.90 $BELFB 40.8% Return Seen

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bel Fuse Inc Cl B (BELFB) 22.90 $BELFB

40.8% Return Seen to Date on SmarTrend Bel Fuse Call (BELFB)
Comtex SmarTrend(R) - Tue Aug 30, 12:40AM CDT
SmarTrend identified an Uptrend for Bel Fuse (NASDAQ:BELFB) on April 25th, 2016 at $16.37. In approximately 4 months, Bel Fuse has returned 40.85% as of today's recent price of $23.05.
BELFB: 22.90 (-0.07)

Shares of BELFB Up 34.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Aug 22, 1:23PM CDT
SmarTrend identified an Uptrend for Bel Fuse (NASDAQ:BELFB) on April 25th, 2016 at $16.37. In approximately 4 months, Bel Fuse has returned 34.34% as of today's recent price of $21.99.
BELFB: 22.90 (-0.07)

Bel Announces New Power Solutions Facility in Taiwan
Marketwire Canada - Sun Aug 14, 8:01PM CDT
The Facility in Taoyuan City Provides Enhanced Support for Bel Power Solutions' Customers Located in Taiwan
BELFB: 22.90 (-0.07), BELFA: 19.46 (+0.08)

Uptrend Call Working As Bel Fuse Stock Rises 24.5% (BELFB)
Comtex SmarTrend(R) - Fri Aug 12, 1:42PM CDT
SmarTrend identified an Uptrend for Bel Fuse (NASDAQ:BELFB) on April 25th, 2016 at $16.37. In approximately 4 months, Bel Fuse has returned 24.53% as of today's recent price of $20.38.
BELFB: 22.90 (-0.07)

Shares of BELFB Up 25.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 05, 1:15AM CDT
SmarTrend identified an Uptrend for Bel Fuse (NASDAQ:BELFB) on April 25th, 2016 at $16.37. In approximately 3 months, Bel Fuse has returned 25.15% as of today's recent price of $20.48.
BELFB: 22.90 (-0.07)

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on Its Class A and Class B Shares
Marketwire Canada - Tue Aug 02, 7:30AM CDT
JERSEY CITY, NJ--(Marketwired - Aug 2, 2016) - BEL FUSE INC. (NASDAQ: BELFA) and (NASDAQ: BELFB) today announced that its Board of Directors has declared regular quarterly cash dividends of $0.06 per share on the Company's Class A common shares and $0.07 per share on the Company's Class B common shares.
BELFB: 22.90 (-0.07), BELFA: 19.46 (+0.08)

Bel Fuse Up 22.0% Since SmarTrend Uptrend Call (BELFB)
Comtex SmarTrend(R) - Thu Jul 28, 1:46PM CDT
SmarTrend identified an Uptrend for Bel Fuse (NASDAQ:BELFB) on April 25th, 2016 at $16.37. In approximately 3 months, Bel Fuse has returned 22.03% as of today's recent price of $19.97.
BELFB: 22.90 (-0.07)

Bel Fuse reports 1Q loss
Automated Insights - Fri May 06, 6:48AM CDT
JERSEY CITY, N.J. (AP) _ Bel Fuse Inc. (BELFB) on Friday reported a first-quarter loss of $100.7 million, after reporting a profit in the same period a year earlier.
BELFB: 22.90 (-0.07), BELFA: 19.46 (+0.08)

Bel Reports First Quarter 2016 Results
Marketwire Canada - Fri May 06, 6:30AM CDT
JERSEY CITY, NJ--(Marketwired - May 6, 2016) - Bel Fuse Inc. ("Bel," or, "the Company" (NASDAQ: BELFA) (NASDAQ: BELFB) today announced preliminary financial results for the first quarter of 2016.
BELFB: 22.90 (-0.07), BELFA: 19.46 (+0.08)

Bel Reschedules First Quarter 2016 Earnings Conference Call to May 6, 2016
Marketwired - Wed Apr 27, 6:30AM CDT
Bel Fuse Inc. ("Bel," or, "the Company" (NASDAQ: BELFA) (NASDAQ: BELFB) is currently in the process of conducting an interim review for impairment of goodwill and other intangible assets. To provide more time for that review, Bel is rescheduling its earnings release of its preliminary financial results for the first quarter of 2016 to approximately 7:30 a.m. EST on Friday, May 6, 2016. Bel has also rescheduled its conference call to 11:00 a.m. EST that morning to discuss its preliminary results for the quarter. To participate in the call, dial (888) 329-8893, conference ID#: 2746213.
BELFB: 22.90 (-0.07), BELFA: 19.46 (+0.08)

Bel Will Report First Quarter 2016 Results on April 28, 2016
Marketwired - Mon Apr 18, 9:01AM CDT
Bel Fuse Inc. ("Bel," or, "the Company" (NASDAQ: BELFA) (NASDAQ: BELFB) will release preliminary financial results for the first quarter of 2016 at approximately 7:30 a.m. EDT on Thursday, April 28, 2016. Bel has scheduled a conference call at 11:00 a.m. EDT that morning to discuss the results with the investment community.
BELFB: 22.90 (-0.07), BELFA: 19.46 (+0.08)

21.3% Return Seen to Date on SmarTrend Bel Fuse Call (BELFB)
Comtex SmarTrend(R) - Mon Apr 11, 12:54PM CDT
SmarTrend identified a Downtrend for Bel Fuse (NASDAQ:BELFB) on October 29th, 2015 at $18.46. In approximately 6 months, Bel Fuse has returned 21.34% as of today's recent price of $14.52.
BELFB: 22.90 (-0.07)

Downtrend Call Working As Bel Fuse Stock Falls 18.3% (BELFB)
Comtex SmarTrend(R) - Fri Apr 01, 1:38PM CDT
SmarTrend identified a Downtrend for Bel Fuse (NASDAQ:BELFB) on October 29th, 2015 at $18.46. In approximately 5 months, Bel Fuse has returned 18.26% as of today's recent price of $15.09.
BELFB: 22.90 (-0.07)

Bel Fuse Down 25.8% Since SmarTrend Downtrend Call (BELFB)
Comtex SmarTrend(R) - Thu Mar 24, 12:17AM CDT
SmarTrend identified a Downtrend for Bel Fuse (NASDAQ:BELFB) on October 29th, 2015 at $18.46. In approximately 5 months, Bel Fuse has returned 25.84% as of today's recent price of $13.69.
BELFB: 22.90 (-0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading